School of Medicine
Showing 1-10 of 310 Results
-
Elias Aboujaoude, MD, MA
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Aboujaoude is a Clinical Professor, researcher and writer at Stanford University's Department of Psychiatry, where he is Chief of the Anxiety Disorders Section and Director of the OCD Clinic and the Impulse Control Disorders Clinic. Besides the compulsivity-impulsivity spectrum, his work has focused on the intersection of technology and psychology, with an emphasis on the problematic use of Internet-related technologies, mental health in a post-privacy world, and the potential for telemedicine interventions such as virtual reality and video-based therapy to increase access to care and advance global health. His books include "Virtually You: The Dangerous Powers of the e-Personality" and "Mental Heath in the Digital Age: Grave Dangers, Great Promise". Dr. Aboujaoude also teaches psychology on the main Stanford campus and at UC Berkeley. Scholarly and media platforms that have featured his work include The New York Times, The Wall Street Journal, The Washington Post, Congressional Quarterly, The Harvard Business Review, The Chronicle of Higher Education, BBC, PBS, and CNN.
-
Connor Adams
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Connor Adams (she/they) is a Clinical Assistant Professor who received her doctorate in psychology from the George Washington University and completed her internship training at Harvard Medical School/Cambridge Health Alliance. Her clinical and research interests center on therapeutic interventions that support recovery for individuals living with serious mental illness. Dr. Adams grounds her work in a psychodynamic perspective, assisting individuals in understanding why they think, feel, and behave the way they do, in order to increase agency and choice. Dr. Adams has specialized training in comprehensive Dialectical Behavior Therapy and provides treatment for individuals with emotion regulation difficulties. She also has specialized training in Cognitive Behavioral Therapy for Psychosis (CBTp). Additionally, Dr. Adams provides individual and group psychotherapy within the psychiatric inpatient treatment setting. She is broadly interested in increasing access to person-centered and recovery-oriented care.
-
Sarah Adler
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsI am interested in the design and delivery of clinical care using, data and technology. I have focused on disordered eating behaviors and obesity.
-
Raag Airan
Assistant Professor of Radiology (Neuroimaging and Neurointervention) and, by courtesy, of Psychiatry and Behavioral Sciences and of Materials Science and Engineering
Current Research and Scholarly InterestsOur goal is to develop and clinically implement new technologies for high-precision and noninvasive intervention upon the nervous system. Every few millimeters of the brain is functionally distinct, and different parts of the brain may have counteracting responses to therapy. To better match our therapies to neuroscience, we develop techniques that allow intervention upon only the right part of the nervous system at the right time, using technologies like focused ultrasound and nanotechnology.
-
Amy Alexander
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsCollege Mental Health, Emotional Support Animals & Service Animals, Women's Health, Mental Health & Well-being in Veterinarians
-
Olivia Altamirano, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsCulturally Sensitive Therapy is a group psychotherapy for people with early psychosis and their families. Study aims are to understand if this treatment is compatible with this population, to assess improvements in family functioning and mental health symptoms, to assess mediating factors (e.g., increased usage of adaptive religious and other cultural beliefs/values), and to assess longevity of improvements. Last, we aim to qualitatively understand participants’ experiences with this treatment.
-
Neal Amin
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Amin is a physician-scientist researcher in the Department of Psychiatry at Stanford University. Dr. Amin received a Bachelor of Arts from Columbia College, Columbia University, and earned MD and PhD degrees in the MSTP at the University of California, San Diego. With his graduate mentor Samuel L. Pfaff, PhD, at the Salk Institute for Biological Studies in La Jolla, CA, he uncovered post-transcriptional, RNA regulatory pathways that are remarkably cell type-specific in motor neurons and are essential for mammalian life (Amin et al, Science 2015; Amin et al, Neuron 2021). He completed psychiatry residency training in the Research Track at Stanford University and postdoctoral studies with Sergiu P. Pasca at Stanford University where he developed human stem cell-derived brain organoid technology, enabling the ability to model the immense neurocellular diversity of the human brain and factors affecting stem cell-derived neuronal maturation (Amin and Pasca, Neuron, 2018; Amin*, Kelley* et al, bioRxiv, 2024; Onesto*, Amin* et al, bioRxiv, 2024). The Amin Lab at Stanford University investigates RNA regulatory mechanisms affecting human brain development and the emergence of neuropathology towards the development of novel therapeutics. His work is funded by the NINDS/NIH, Deeda Blair Research Initiative, and the Brain and Behavior Research Foundation. Dr. Amin's research leverages his unique background as a board-certified, practicing Stanford physician and researcher with 20 years of bench research experience spanning mouse genetics, human neuropathology, advanced stem cell models of the brain, and cell type-specific RNA processing pathways.
